Step-by-step lifestyle changes that can improve urologic health in men, part I: What do i tell my patients?

Primary Care - Clinics in Office Practice

Volumn 33, Issue 1, 2006, Pages 139-163

  Moyad, Mark A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SELENIUM;

BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EXERCISE; FITNESS; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MEN'S HEALTH; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; UNITED STATES; UROLOGICAL CARE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIET; HEALTH PROMOTION; HUMANS; LIFE STYLE; LIPIDS; MALE; MALE UROGENITAL DISEASES; PHYSICAL FITNESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33644615376     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2005.11.002     Document Type: Review

References (137)

1. R.O. Bonow, L.A. Smaha, and S.C. Smith The international burden of cardiovascular disease: responding to the emerging epidemic Circulation 106 2002 1602 1605
2. World Heart Federation web site. Available at: http://www.world-heart. org/introduction/call_to_action.html. Accessed August 20, 2002.
3. World Health Report Mental Health: New Understanding, New Hope 2001 World Health Organization Geneva, Switzerland p. 144-9
4. C.M. Michaud, C.J.L. Murray, and B.R. Bloom Burden of disease: implications for future research JAMA 285 2001 535 539
5. C.J.L. Murray, and A.D. Lopez Mortality by cause for eight regions of the world: Global Burden of Disease Study Lancet 349 1997 1269 1276
6. R. Twombly Cancer surpasses heart disease as leading cause of death for all but the very elderly J Natl Cancer Inst 97 2005 330 331
7. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224
8. P.T. Scardino The prevention of prostate cancer-The dilemma continues N Engl J Med 349 2003 297 299
9. T. Reynolds Prostate cancer prevention trial yields positive results, but with a few cautions J Natl Cancer Inst 95 2003 1030 1031
10. L.C. Clark, G.F. Combs Jr., and B.W. Turnbull Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group JAMA 276 1996 1957 1963
11. C.J. Newschaffer, K. Otani, and M.K. McDonald Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort J Natl Cancer Inst 92 2000 613 621
12. P.A. Groome, S.L. Rohland, and M.D. Brundage The relative risk of early death from comorbid illnesses among prostate cancer patients receiving curative treatment J Urol 173 Suppl. 2005 53
13. K. Senior Atherosclerosis gene increases susceptibility to prostate cancer Lancet 360 2002 928
14. A.I. Neugut, D.J. Rosenberg, and H. Ahsan Association between coronary heart disease and cancers of the breast, prostate, and colon Cancer Epidemiol Biomarkers Prev 7 1998 869 873
15. H.I. Peterson Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors Anticancer Res 6 1986 251
16. L. Sandfeldt, and R.G. Hahn Cardiovascular risk factors correlate with prostate size in men with bladder outlet obstruction BJU Int 92 2003 64 68
17. H. Solomon, J.W. Man, and A.S. Wierzbicki Relation of erectile dysfunction to angiographic coronary artery disease Am J Cardiol 91 2003 230 231
18. C.M. Clark, and J.H.T. Karlawish Alzheimer disease: Current concepts and emerging diagnostic and therapeutic strategies Ann Intern Med 138 2003 400 410
19. M.A. Moyad Emphasizing and promoting overall health and nontraditional treatments after a prostate cancer diagnosis Semin Urol Oncol 17 1999 119 124
20. I.S. Nash, L. Mosca, and R.S. Blumenthal Contemporary awareness and understanding of cholesterol as a risk factor: Results of an American Heart Association National Survey Arch Intern Med 163 2003 1597 1600
21. The Expert Panel Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2498
22. S.M. Grundy, J.I. Cleeman, and N.B. Marz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Circulation 110 2004 227 239
23. L. Mosca C-reactive protein-to screen or not screen? N Engl J Med 347 2002 1615 1616
24. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
25. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen for the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators Statin therapy, LDL cholesterol, C-reactive protein, and coronary heart disease N Engl J Med 352 2005 29 38
26. P.M. Ridker, C.P. Cannon, and D. Morrow C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
27. The Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke. A Meta-analysis JAMA 288 2002 2015 2022
28. K.M. Kostner, and G.M. Kostner Lipoprotein(a): still an enigma? Curr Opin Lipidol 13 2002 391 396
29. A.A. Ariyo, C. Thach, R. Tracy for the Cardiovascular Health Study Investigators Lp(a) lipoprotein, vascular disease, and mortality in the elderly N Engl J Med 349 2003 2108 2115
30. W.E. Kraus, J.A. Houmard, and B.D. Duscha Effects of the amount and intensity of exercise on plasma lipoproteins N Engl J Med 347 2002 1483 1492
31. J. Hammarsten, and B. Hogstedt Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 2001 151 158
32. A.V. Chobanian, G.L. Bakris, H.R. Black for the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Hypertension 42 2003 1206 1252
33. S.P. Whelton, A. Chin, X. Xin, and J. He Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials Ann Intern Med 136 2002 493 503
34. st Annual Meeting, May 13-17, 2005, Orlando, Florida.
35. M.A. Moyad Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective Urology 59 Suppl 4A 2002 41 50
36. M.A. Moyad Current methods used for defining, measuring, and treating obesity Semin Urol Oncol 19 2001 247 256
37. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
38. M. Shike, L. Latkany, and E. Riedel Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial J Clin Oncol 20 2002 3592 3598
39. S. Zhu, S.B. Heymsfield, and H. Toyoshima Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors Am J Clin Nutr 81 2005 409 415
40. st American Society of Clinical Oncology Annual Meeting 2005;abstract 4626, page 409. May 13-17, Orlando, Florida.
41. M.A. Moyad Osteoporosis: a rapid review of risk factors and screening methods Urol Oncol: Seminars and Original Investigations 21 5 2003 375 379
42. S.J. Freedland, and W.J. Aronson Obesity and prostate cancer Urology 65 2005 433 439
43. S.O. Andersson, A. Wolk, and R. Bergstrom Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers J Natl Cancer Inst 89 1997 385 389
44. A.G. Schuurman, P.A. van den Brandt, and E. Dorant Association of energy and fat intake with prostate carcinoma risk: results from the Netherlands Cohort Study Cancer 86 1999 1019 1027
45. A.G. Schuurman, R.A. Goldbohm, and E. Dorant Anthropometery in relation to prostate cancer risk in the Netherlands Cohort Study Am J Epidemiol 151 2000 541 549
46. O.P. Heinonen, D. Albanes, and J. Virtamo Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial J Natl Cancer Inst 90 1998 440 446
47. N.M. Aziz, T. Hartman, and M. Barrett Weight and prostate cancer in the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Trial ASCO 19 2000 647a
48. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults N Engl J Med 348 2003 1625 1638
49. C.L. Amling, R.H. Riffenburgh, and Sun L Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 22 2004 439 445
50. S.J. Freedland, W.J. Aronson, and C.J. Kane Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital Database Study Group J Clin Oncol 22 2004 446 453
51. E. Giovannucci, E.B. Rimm, and Y. Liu Body mass index and risk of prostate cancer in US health professionals J Natl Cancer Inst 95 2003 1240 1244
52. J. Stevens, J. Cai, and E.R. Pamuk The effect of age on the association between body-mass index and mortality N Engl J Med 338 1998 1 7
53. E.E. Calle, M.J. Thun, and J.M. Petrelli Body-mass index and mortality in a prospective cohort of US adults N Engl J Med 341 1997 1097 1105
54. R.J. Kuczmarski, M.D. Carroll, and K.M. Flegal Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988 to 1994) Obes Res 5 1997 542 548
55. M.A. Moyad Obesity, interrelated mechanisms, and exposures and kidney cancer Semin Urol Oncol 19 2001 270 279
56. C.G. Bacon, M.A. Mittleman, and I. Kawachi Sexual function in men older than 50 years of age: results from the Health Professionals Follow-up Study Ann Intern Med 139 2003 161 168
57. M.K. Walczak, N. Lokhandwala, and M.B. Hodge Prevalence of cardiovascular risk factors in erectile dysfunction J Gend Specif Med 5 2002 19 24
58. E.N. Taylor, M.J. Stampfer, and G.C. Curhan Obesity, weight gain, and the risk of kidney stones JAMA 293 2005 455 462
59. C.M. Friedenreich Physical activity and cancer prevention: from observational to intervention research Cancer Epidemiol Biomark Prev 10 2001 287 301
60. E.L. Giovannucci, Y. Liu, and M.F. Leitzmann A prospective study of physical activity and incident and fatal prostate cancer Arch Intern Med 165 2005 1005 1010
61. M. Tanasescu, M.F. Leitzmann, and E.B. Rimm Exercise type and intensity in relation to coronary heart disease in men JAMA 288 2002 1994 2000
62. E.T. Poehlman, and C. Melby Resistance training and energy balance Int J Sport Nutr 8 1998 143 159
63. E.T. Poehlman, R.V. Dvorak, and W.F. DeNino Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women J Clin Endocrinol Metab 85 2000 2463 2468
64. B. Prabhakaran, E.A. Dowling, and J.D. Branch Effect of 14 weeks of resistance training on lipid profile and body fat percentage in premenopausal women Br J Sports Med 33 1999 190 195
65. B.F. Hurley, and S.M. Roth Strength training in the elderly Sports Med 30 2000 249 268
66. R.J. Segal, R.D. Reid, and K.S. Courneya Resistance training in men receiving androgen deprivation therapy for prostate cancer J Clin Oncol 21 2003 1653 1659
67. E.A. Platz, I. Kawachi, and E.B. Rimm Physical activity and benign prostatic hyperplasia Arch Intern Med 158 1998 2349 2356
68. K. Esposito, F. Giugliano, and C. Di Palo Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial JAMA 291 2004 2978 2984
69. C.S. Saigal Obesity and erectile dysfunction: common problems, common solution? JAMA 291 2004 3011 3012
70. M.L. Slattery, S. Edwards, and K. Curtin Physical activity and colorectal cancer Am J Epidemiol 158 2003 214 224
71. J.A. Blumenthal, M.A. Babyak, and K.A. Moore Effects of exercise training on older patients with major depression Arch Intern Med 159 1999 2349 2356
72. M. Babyak, J.A. Blumenthal, and S. Herman Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months Psychosom Med 62 2000 633 638
73. F.B. Hu, W.C. Willett, and T. Li Adiposity as compared with physical activity in predicting mortality among women N Engl J Med 351 2004 2694 2703
74. J.C. Grable, and S. Ternullo Smoking cessation from office to bedside. An evidence-based, practical approach Postgrad Med 114 2 2003 45 48 51-54
75. D. Ornish, W. Fair, and E. Pettengill Can lifestyle changes reverse prostate cancer? J Urol 169 4 2003 74
76. F.F. Samaha, N. Iqbal, and P. Seshadri A low-carbohydrate as compared with a low-fat diet in severe obesity N Engl J Med 348 2003 2074 2081
77. G.D. Foster, H.R. Wyatt, and J.O. Hill A randomized trial of a low-carbohydrate diet for obesity N Engl J Med 348 2003 2082 2090
78. A.W. Hsing, S. Chua Jr., and Y.T. Gao Prostate cancer risk and serum levels of insulin and leptin: a population-based study J Natl Cancer Inst 93 2001 783 789
79. L.S. Augustin, S. Franceschi, and D.J.A. Jenkins Glycemic index in chronic disease: a review Eur J Clin Nutr 56 2002 1049 1071
80. A.W. Hsing, Y.-T. Gao, and S. Chua Jr. Insulin resistance and prostate cancer risk J Natl Cancer Inst 95 2003 67 71
81. S.H. Jee, H. Ohrr, and J.W. Sull Fasting serum glucose level and cancer risk in Korean men and women JAMA 293 2005 194 202
82. M.L. Dansinger, J.A. Gleason, and J.L. Griffith Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for weight loss and heart disease risk reduction: a randomized trial JAMA 293 2005 43 53
83. B.J. Rolls, E.L. Morris, and Roe LS Portion size of food affects energy intake in normal-weight and overweight men and women Am J Clin Nutr 76 2002 1207 1213
84. M.A. Pereira, A.I. Kartashov, and C.B. Ebbeling Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis Lancet 365 2005 36 42
85. L.J. Hsieh, B. Carter, and P.K. Landis Association of energy intake with prostate cancer in a long-term aging study: Baltimore Longitudinal Study of Aging (United States) Urology 61 2003 297 301
86. L.K. Heilbronn, and E. Ravussin Calorie restriction and aging: review of the literature and implications for studies in humans Am J Clin Nutr 78 2003 361 369
87. S. Pirozzo, C. Summerbell, and C. Cameron Advice on low-fat diets for obesity Cochrane Database Syst Rev 2 2002 CD003640
88. J.O. Hill, and J.C. Peters Environmental contributions to the obesity epidemic Science 280 1998 1371 1374
89. P. Mukherjee, A.V. Sotnikov, and H.J. Mangian Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression J Natl Cancer Inst 91 1999 512 523
90. M.C. Bosland, I. Oakley-Girvan, and A.S. Whittemore Dietary fat, calories, and prostate cancer risk J Natl Cancer Inst 91 1999 489 491
91. E.W. Gregg, R.B. Gerzoff, and T.J. Thompson Intentional weight loss and death in overweight and obese US adults 35 years of age and older Ann Intern Med 138 2003 383 389
92. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Available at: http://www.nhlbi.nih.gov/ guidelines/obesity/ob_home.htm. Accessed September 30, 2002.
93. A. Keys, A. Menotti, and M.J. Karvonen The diet and 15-year death rate in the Seven Countries Study Am J Epidemiol 124 1986 903 915
94. D.J. Gordon Cholesterol and mortality: what can meta-analysis tell us? L.L. Gallo Cardiovascular disease 2: cellular and molecular mechanisms, prevention, and treatment 1995 Plenum Press New York 333 340
95. D.J. Gordon Cholesterol lowering and total mortality B.M. Rifkind Lowering cholesterol in high-risk individuals and populations 1995 Marcel Dekker, Inc New York 333 348
96. M.A. Moyad The ABCs of nutrition and supplements for prostate cancer 2000 JW Edwards Publishing Ann Arbor (MI)
97. F. Meyer, I. Bairati, and R. Shadmani Dietary fat and prostate cancer survival Cancer Causes Control 10 1999 245 251
98. T.J. Key, G.E. Fraser, and M. Thorogood Mortality in vegetarians and non-vegetarians: detailed findings from a collaborative analysis of 5 prospective studies Am J Clin Nutr 70 suppl 1999 516S 524S
99. J.N. Yu, J.A. Cunningham, and S. Rosenberg Thouin Hyperlipidemia Prim Care 27 2000 541 587
100. R.P. Mensink, and M.B. Katan Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials Arterioscler Thromb 12 1992 911 919
101. F.B. Hu, R.M. van Dam, and Liu S Diet and risk of type II diabetes: the role of types of fat and carbohydrate Diabetologia 44 2001 805 817
102. J. Salmeron, F.B. Hu, and J.E. Manson Dietary fat intake and risk of type 2 diabetes in women Am J Clin Nutr 73 2001 1019 1026
103. S.M. Innis, T.J. Green, and T.K. Halsey Variability in the trans fatty acid content of foods within a food category: implications for estimation of dietary trans fatty acid intakes J Am Coll Nutr 18 1999 255 260
104. M.T. Clandinin, and M.S. Wilke Do trans fatty acids increase the incidence of type 2 diabetes? Am J Clin Nutr 73 2001 1001 1002
105. R.N. Lemaitre, I.B. King, and T.E. Raghunathan Cell membrane trans-fatty acids and the risk of primary cardiac arrest Circulation 105 2002 697 701
106. G.J. Nelson Dietary fat, trans fatty acids, and risk of coronary heart disease Nutr Rev 56 1998 250 252
107. M.B. Katan Trans fatty acids and plasma lipoproteins Nutr Rev 58 2000 188 191
108. R.P. Mensink, and M.B. Katan Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects N Engl J Med 323 1990 439 445
109. A. Ascherio, M.B. Katan, and P.L. Zock Trans fatty acids and coronary heart disease N Engl J Med 340 1999 1994 1998
110. P. Nestel, M. Noakes, and B.E. Belling Plasma lipoprotein and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet J Lipid Res 33 1992 1029 1036
111. K. Sundram, A. Ismail, and K.C. Hays Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans J Nutr 127 1997 514S 520S
112. N.M. de Roos, M.L. Bots, and E. Siebelink Flow-mediated vasodilation is not impaired when HDL-cholesterol is lowered by substituting carbohydrates for monounsaturated fat Br J Nutr 86 2001 181 188
113. J.C. Lovejoy Dietary fatty acids and insulin resistance Curr Atheroscler Rep 1 1999 215 220
114. J.E. Kinsella, G. Bruckner, and Mai J Metabolism of trans fatty acids with emphasis on the effects of trans, trans-octadecadienoate on lipid composition, essential fatty acid, and prostaglandins: an overview Am J Clin Nutr 34 1981 2307 2318
115. E.G. Hill, S.B. Johnson, and L.D. Lawson Perturbation of the metabolism of essential fatty acids by dietary hydrogenated vegetable oil Proc Natl Acad Sci USA 79 1982 953 957
116. C. Byrne, H. Rockett, and M.D. Holmes Dietary fat, fat subtypes, and breast cancer risk: lack of an association among postmenopausal women with no history of benign breast disease Cancer Epidemiol Biomarkers Prev 11 2002 261 265
117. M.L. Slattery, J. Benson, and K.N. Ma Trans-fatty acids and colon cancer Nutr Cancer 39 2001 170 175
118. L.E. Voorrips, H.A. Brants, and A.F. Kardinaal Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer Am J Clin Nutr 76 2002 873 882
119. I.B. King, A.R. Kristal, and S. Schaffer Serum trans-fatty acids are associated with risk of prostate cancer in beta-carotene and retinol efficacy trial Cancer Epidemiol Biomarkers Prev 14 2005 988 992
120. S. Stender, and J. Dyerberg Influence of trans fatty acids on health Ann Nutr Metab 48 2004 61 66
121. United States Food and Drug Administration web site. Available at: http://www.fda.gov/oc/initiatives/transfat. Accessed February 15, 2004.
122. M.A. Moyad Dietary fat reduction to reduce prostate cancer risk: controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture Urology 59 Suppl 4A 2002 51 62
123. D.E. Laaksonen, K. Nyyssonen, and L. Niskanen Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids Arch Intern Med 165 2005 193 199
124. W.E. Connor, and D.S. Lin The effect of shellfish in the diet upon the plasma lipid levels in humans Metabolism 31 1982 1046 1051
125. M.T. Childs, C.S. Dorsett, and A. Failor Effect of shellfish consumption on cholesterol absorption in normolipidemic men Metabolism 36 1987 31 35
126. L. Zhuang, J. Kim, and R.M. Adam Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts J Clin Invest 115 2005 959 968
127. P. Henriksson, M. Eriksson, and S. Ericsson Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate Lancet 2 8673 1989 1178 1180
128. N.C.W. Wong The beneficial effects of plant sterols on serum cholesterol Can J Cardiol 17 2001 715 721
129. M.B. Katan, S.M. Grundy, P. Jones for the Stresa Workshop Participants Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels Mayo Clin Proc 78 2003 965 978
130. E.J. Schaefer Lipoproteins, nutrition, and heart disease Am J Clin Nutr 75 2002 191 212
131. A.F. Vuorio, H. Gylling, and H. Turtola Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation Arterio Thromb Vasc Biol 20 2000 500 506
132. H. Gylling, and T.A. Miettinen Cholesterol reduction by different plant stanol mixtures and with variable fat intake Metabolism 48 1999 575 580
133. M.A. Hallikainen, and M.I. Uusitupa Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects Am J Clin Nutr 69 1999 403 410
134. H.F.J. Hendriks, J.A. Weststrate, and T. van Vliet Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects Eur J Clin Nutr 53 1999 319 327
135. H. Gylling, R. Radhakrishnan, and T.A. Miettinen Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol Circulation 96 1997 4226 4231
136. T.A. Miettinen, P. Puska, and H. Gylling Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population N Engl J Med 333 1995 1308 1312
137. H.T. Vanhanen, S. Blomqvist, and C. Ehnholm Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment J Lipid Res 34 1993 1535 1544